Singapore markets open in 8 hours 56 minutes
Straits Times Index
3,348.87 +12.28 (+0.37%) S&P 500
5,267.02 -10.49 (-0.20%) Dow
38,438.33 -247.99 (-0.64%) Nasdaq
16,775.74 +40.72 (+0.24%) Bitcoin USD
69,589.67 +1,461.12 (+2.14%) CMC Crypto 200
1,488.22 +20.28 (+1.38%)
Roche Holding AG (0TDF.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 06:28PM BST
| Previous close | 31.25 |
| Open | 0.00 |
| Bid | 25.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 352 |
| Market cap | 215.712B |
| Beta (5Y monthly) | 0.16 |
| PE ratio (TTM) | 0.15 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Pharma Stock Roundup: JNJ, MRK M&A Deals, SNY, RHHBY Drugs' Priority Review & More
J&J (JNJ) and Merck (MRK) announce the acquisitions of private biotechs. The FDA grants Priority Review tags to Sanofi's (SNY) and Roche's (RHHBY) regulatory applications.
- Zacks
Roche's (RHHBY) Inavolisib NDA Gets FDA Priority Review Tag
The FDA grants priority review to Roche's (RHHBY) NDA for the inavolisib combination regimen for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation.
- Zacks
Pharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More
AstraZeneca (AZN) announces an ambitious target of achieving $80 billion in revenues by 2030. Pfizer (PFE) announces a multi-year, multi-phase cost reduction program.
© 2024 Yahoo. All rights reserved.